Cargando…
Effects of propolis on warfarin efficacy
INTRODUCTION: Warfarin is commonly used to avoid thromboembolism, predominantly for cardiovascular pathologies. However, the consumption of several herbal products is not permitted during its use due to the associated interactions. Propolis is a popular phytotherapy product made by honey bees. The u...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404127/ https://www.ncbi.nlm.nih.gov/pubmed/28515748 http://dx.doi.org/10.5114/kitp.2017.66929 |
_version_ | 1783231531616043008 |
---|---|
author | Akbay, Esin Özenirler, Çiğdem Çelemli, Ömür Gençay Durukan, Ahmet Baris Onur, Mehmet Ali Sorkun, Kadriye |
author_facet | Akbay, Esin Özenirler, Çiğdem Çelemli, Ömür Gençay Durukan, Ahmet Baris Onur, Mehmet Ali Sorkun, Kadriye |
author_sort | Akbay, Esin |
collection | PubMed |
description | INTRODUCTION: Warfarin is commonly used to avoid thromboembolism, predominantly for cardiovascular pathologies. However, the consumption of several herbal products is not permitted during its use due to the associated interactions. Propolis is a popular phytotherapy product made by honey bees. The use of propolis has been dramatically increasing in recent times. AIM: To evaluate the possible interactions between propolis and warfarin in a mouse model with determination of the international normalized ratio (INR) values. MATERIAL AND METHODS: CD-1 mice were employed in the experimental model. The mice were warfarinized, and propolis was administered simultaneously. The INR values were obtained. All animals were sacrificed at the end of the study. RESULTS: The baseline INR value was 0.8 ±0.1. After 72 h, the INR value increased as expected. The INR value was 7.28 ±1.08 in the control group and 5.8 ±2.88 in the propolis group. At the end of the study, the INR value was 1.3 ±0.37. Propolis interacted with warfarin and caused a decrease in the INR value. CONCLUSIONS: Propolis interactions, especially with warfarin, should be kept in mind and further studied. Healthcare specialists should be aware of this possible interaction between warfarin and propolis and inform patients about it. |
format | Online Article Text |
id | pubmed-5404127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-54041272017-05-17 Effects of propolis on warfarin efficacy Akbay, Esin Özenirler, Çiğdem Çelemli, Ömür Gençay Durukan, Ahmet Baris Onur, Mehmet Ali Sorkun, Kadriye Kardiochir Torakochirurgia Pol Experimental Cardiovascular and Lung Research INTRODUCTION: Warfarin is commonly used to avoid thromboembolism, predominantly for cardiovascular pathologies. However, the consumption of several herbal products is not permitted during its use due to the associated interactions. Propolis is a popular phytotherapy product made by honey bees. The use of propolis has been dramatically increasing in recent times. AIM: To evaluate the possible interactions between propolis and warfarin in a mouse model with determination of the international normalized ratio (INR) values. MATERIAL AND METHODS: CD-1 mice were employed in the experimental model. The mice were warfarinized, and propolis was administered simultaneously. The INR values were obtained. All animals were sacrificed at the end of the study. RESULTS: The baseline INR value was 0.8 ±0.1. After 72 h, the INR value increased as expected. The INR value was 7.28 ±1.08 in the control group and 5.8 ±2.88 in the propolis group. At the end of the study, the INR value was 1.3 ±0.37. Propolis interacted with warfarin and caused a decrease in the INR value. CONCLUSIONS: Propolis interactions, especially with warfarin, should be kept in mind and further studied. Healthcare specialists should be aware of this possible interaction between warfarin and propolis and inform patients about it. Termedia Publishing House 2017-03-31 2017-03 /pmc/articles/PMC5404127/ /pubmed/28515748 http://dx.doi.org/10.5114/kitp.2017.66929 Text en Copyright: © 2017 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska) http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Experimental Cardiovascular and Lung Research Akbay, Esin Özenirler, Çiğdem Çelemli, Ömür Gençay Durukan, Ahmet Baris Onur, Mehmet Ali Sorkun, Kadriye Effects of propolis on warfarin efficacy |
title | Effects of propolis on warfarin efficacy |
title_full | Effects of propolis on warfarin efficacy |
title_fullStr | Effects of propolis on warfarin efficacy |
title_full_unstemmed | Effects of propolis on warfarin efficacy |
title_short | Effects of propolis on warfarin efficacy |
title_sort | effects of propolis on warfarin efficacy |
topic | Experimental Cardiovascular and Lung Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404127/ https://www.ncbi.nlm.nih.gov/pubmed/28515748 http://dx.doi.org/10.5114/kitp.2017.66929 |
work_keys_str_mv | AT akbayesin effectsofpropolisonwarfarinefficacy AT ozenirlercigdem effectsofpropolisonwarfarinefficacy AT celemliomurgencay effectsofpropolisonwarfarinefficacy AT durukanahmetbaris effectsofpropolisonwarfarinefficacy AT onurmehmetali effectsofpropolisonwarfarinefficacy AT sorkunkadriye effectsofpropolisonwarfarinefficacy |